118 results
Page 4 of 6
8-K
56eno ipaj81
26 Jan 09
Departure of Directors or Principal Officers
12:00am
425
EX-99.1
mvuoyu a2z87bd
26 Sep 08
Business combination disclosure
12:00am
425
do5wwa0xboyhey1
25 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.1
aj3rj3s10g2 da
25 Sep 08
Ligand to Acquire Pharmacopeia Webcast
12:00am
425
EX-99.1
c1936q0rjzref
25 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.2
t1c9g5f7480obff89kh
24 Sep 08
1 Joseph A. Mollica, Ph.D., Chairman of the Board, Interim President & CEO, Pharmacopeia John L. Higgins, President & CEO
12:00am
425
EX-99.2
xcfcfn8
24 Sep 08
Business combination disclosure
12:00am
8-K
EX-10
29h4uhq64b8lp 7tns
4 May 07
Termination of a Material Definitive Agreement
12:00am
424B3
1hl8s1yft8ef 4lo42q
4 May 07
Prospectus supplement
12:00am
424B3
4gjpl8ykt1l507es 2o
6 Feb 07
Prospectus supplement
12:00am
8-K
EX-99.1
cd9wzcqjh56
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
DEFM14A
raioljj3wt3deyg9r5e
24 Jan 07
Proxy related to merger
12:00am
424B3
0nrc4hvbkc j6c
16 Jan 07
Prospectus supplement
12:00am
CORRESP
tc63ots6eomwoiy 2mty
14 Dec 06
Correspondence with SEC
12:00am
PRER14A
9iv8qrkqr
14 Dec 06
Preliminary revised proxy
12:00am
PREM14A
x4pfe8
6 Nov 06
Preliminary proxy related to merger
12:00am
8-K
EX-99
tyv43g9eay
11 Sep 06
Regulation FD Disclosure
12:00am